{
    "data": [
        {
            "id": "4511531",
            "title": "Amerisafe signals durable organic growth strategy as voluntary premiums rise 10.6% while maintaining 90.6% combined ratio",
            "description": "<html><body><p>Earnings Call Insights: AMERISAFE, Inc. (AMSF) Q3 2025</p>\n<h3>Management View</h3>\n<ul>\n<li>CEO Janelle Frost highlighted, \"We are pleased that our growth strategy in this competitive market is yielding a healthy 20.5% return on average equity and a 90.6% combined ratio for the quarter. Our continued success in the market reflects the strength of the AMERISAFE value proposition.\" Frost emphasized disciplined underwriting, robust new business production, and strong renewal performance, noting, \"This is our sixth consecutive quarter of top line growth. Voluntary premiums on policies written in the quarter grew 10.6%. Combined with audit premiums, our gross premiums written grew 7.2% and net earned grew 6.2% over the third quarter of 2024.\" She described the company's claims handling practices and risk selection as consistent, stating, \"Our accident year loss ratio was in line with the prior year end quarter at 71%. Frequency remains at historically low levels, while severity continues to not higher on a year-over-year basis.\" Frost also announced a regular quarterly dividend of $0.39 per share and a $1 special dividend, citing AMERISAFE's balanced capital deployment strategy and nearly $50 per share in total dividends declared over the past 13 years.</li>\n<li>CFO Anastasios Omiridis stated, \"For the third quarter of 2025, AMERISAFE reported net income of $13.8 million or $0.72 per diluted share and operating net income of $10.6 million or $0.55 per diluted share.\" Omiridis reported gross written premiums of $80.3 million, a 7.2% increase, and total underwriting and other expenses of $22.1 million, resulting in an expense ratio of 31.1%. He remarked on the company's investment portfolio and capital position, noting a book value per share increase to $14.47, up 7.1% year-to-date, and statutory surplus of $259 million.</li>\n</ul>\n<h3>Outlook</h3>\n<ul>\n<li>Management reiterated confidence in the durability of the current growth strategy. Frost explained, \"I believe it has longevity. And we've said since the very beginning when we started paying out the special dividend, part of the reason that we were returning that capital to shareholders is because we had internally made the decision. It wasn't the right time to really pour that into organic growth because we wanted that growth to be profitable growth. So now we've had these quarters of top line growth, and it's starting to flow through on the earnings. And so that dividend, we're using that capital and deploying that capital towards that organic growth.\"</li>\n<li>Omiridis commented on underwriting leverage, stating, \"It is going up, but it's at $1. I mean from our standpoint, I don't think it's really changed. It's -- I think it's increased a little bit, but it's right at $1.\" He identified $1.5 as a comfortable upper bound for leverage.</li>\n</ul>\n<h3>Financial Results</h3>\n<ul><li>AMERISAFE reported net income of $13.8 million or $0.72 per diluted share and operating net income of $10.6 million or $0.55 per diluted share. Gross written premiums totaled $80.3 million, increasing 7.2% from the prior-year quarter. Audit premiums contributed $2.5 million, while voluntary premium growth was 10.6%. The expense ratio was 31.1%. Net investment income was $6.6 million, and the investment portfolio at quarter end stood at $817 million. Book value per share reached $14.47, and statutory surplus was $259 million. The company repurchased approximately 31,000 shares at an average cost of $43.72 per share.</li></ul>\n<h3>Q&amp;A</h3>\n<ul>\n<li>Matthew Carletti, Citizens JMP Securities: Asked about sources of voluntary premium growth and whether it was broad-based or specific to segments. Frost responded that growth was broad-based, supported by a 2.7% quarter-over-quarter increase in policy count and 11% year-over-year policy count growth. She attributed growth to strong renewal retention, expansion in insured payrolls, and the company's approach to claims handling.</li>\n<li>Carletti further inquired about the special dividend and capital allocation, suggesting it signals management's confidence in durable growth. Frost agreed, stating, \"that is exactly what you should infer into the dividend. ... we're using that capital and deploying that capital towards that organic growth.\"</li>\n<li>Mark Hughes, Truist Securities: Inquired about underwriting leverage, medical inflation, loss cost trends, wage growth, large losses, competition, audit premium outlook, and construction segment performance. Omiridis explained leverage is around $1 and could comfortably go to $1.5. Frost discussed wage growth of 6.7% in the quarter, with new employee count up 2%. Large losses over $1 million totaled 17 year-to-date, up from 13 last year. She described the competitive environment as \"extremely competitive\" but stable in terms of competitors' appetite. Frost also addressed audit premium outlook and construction trends, noting insured base economies are holding up.</li>\n<li>Robert Farnam, Janney Montgomery Scott: Asked about claims staffing, state expansion, and fee schedules. Frost indicated claims staff levels have remained unchanged despite growth; geographic expansion is always under consideration but not imminent. She noted fee schedules are updated regularly and currently not a legislative focus.</li>\n</ul>\n<h3>Sentiment Analysis</h3>\n<ul>\n<li>Analysts were positive in tone, with Carletti and Hughes expressing approval of growth trends and capital strategy, while seeking clarity on competitive positioning and underlying drivers. Carletti remarked, \"I'm glad I put those puzzle pieces together okay.\"</li>\n<li>Management maintained a confident and measured tone throughout, emphasizing consistency, long-term strategy, and prudent capital deployment. Frost repeatedly referenced \"confidence,\" \"consistency,\" and \"disciplined growth.\" This tone was consistent with prior quarters, though the current call included greater emphasis on the durability and longevity of growth.</li>\n<li>Compared to the previous quarter, analyst sentiment remained positive but pressed for details on the sustainability of growth and capital allocation, while management confidence appeared more pronounced as multi-quarter growth trends solidified.</li>\n</ul>\n<h3>Quarter-over-Quarter Comparison</h3>\n<ul>\n<li>Voluntary premium growth remained strong, though slightly below the 12.8% reported last quarter; policy count growth was also robust. The accident year loss ratio was consistent at 71%. Book value per share and statutory surplus continued to rise.</li>\n<li>Management increased focus on the durability of growth and capital deployment for organic expansion, reflected in the announcement of a $1 special dividend and strategic commentary.</li>\n<li>Analysts continued to focus on growth drivers, market conditions, and capital allocation, with questions evolving from incremental growth to the sustainability and scalability of current trends.</li>\n<li>The tone of the management commentary grew more assertive regarding the company's value proposition and ability to maintain profitable growth in a competitive market.</li>\n</ul>\n<h3>Risks and Concerns</h3>\n<ul>\n<li>Frost acknowledged medical inflation as a monitored risk, though mitigated by fee schedules in workers' compensation. Utilization trends and home health services are areas of focus, with no significant data-driven concerns identified yet.</li>\n<li>Large loss frequency is up year-to-date, though overall claim frequency remains low relative to policy count growth. Frost described large losses as \"lumpy.\" </li>\n<li>Competitive pressures remain high but stable. Audit premium growth may moderate, depending on wage trends and broader economic conditions.</li>\n<li>Fee schedules are updated regularly and could be influenced by legislative changes, but no immediate risks identified.</li>\n</ul>\n<h3>Final Takeaway</h3>\n<p>AMERISAFE management underscores that disciplined underwriting, robust new business, and strong retention have delivered another quarter of profitable growth, with a 20.5% return on equity and 90.6% combined ratio. The company continues to deploy capital toward organic growth while maintaining shareholder rewards through dividends and buybacks. Management expresses confidence that current momentum is sustainable and positions AMERISAFE for long-term value creation in a competitive environment.</p>\n<p><a href=\"https://seekingalpha.com/symbol/amsf/earnings/transcripts\">Read the full Earnings Call Transcript</a></p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511531-amerisafe-signals-durable-organic-growth-strategy-as-voluntary-premiums-rise-10_6-percent",
            "pub_date": "2025-10-31 00:10:45",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511532",
            "title": "Ontex reports Q3 results",
            "description": "<html><body><ul>\n<li>Ontex <a href=\"https://ontex.com/wp-content/uploads/2025/10/25Q3PressReleaseEN.pdf\" rel=\"nofollow\" target=\"_blank\">press release</a>  (ONXXF): Q3 operating profit from continuing operations was €29 million, compared to €8 million in 2024.</li>\n<li>Revenue of €445 million, down 3.8% like-for-like year on year due to softer market demand, and 3.7% up versus Q2 on volume growth driven by contract gains.</li>\n<li>Adj. EBITDA margin at 11.4%, 0.6pp lower year on year, and 3.0pp up versus Q2 on revenue recovery and cost optimization.</li>\n<li>\n<strong>Full-year outlook maintained:</strong> Revenue to reduce by low single digits like-for-like and adjusted EBITDA to be in a range of €200 million to €210 million.</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511532-ontex-reports-q3-results",
            "pub_date": "2025-10-31 00:10:45",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511528",
            "title": "Kongsberg Gruppen ASA reports Q3 results",
            "description": "<html><body><ul>\n<li>Kongsberg Gruppen ASA <a href=\"https://www.kongsberg.com/investor-relations/reports-and-presentations/other-presentations/\" rel=\"nofollow\" target=\"_blank\">press release</a>  (NSKFF): Q3 EPS of NOK 1.93.</li>\n<li><p>Revenues of NOK 13.3B (+12% Y/Y).</p></li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511528-kongsberg-gruppen-asa-reports-q3-results",
            "pub_date": "2025-10-31 00:05:38",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511469",
            "title": "Analysts largely impressed with Meta's Q3, but AI spending plans remind of Metaverse days",
            "description": "<html><body><p data-pm-slice=\"0 0 []\">Shares in Meta Platforms (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/META\" title=\"Meta Platforms, Inc.\">META</a></span>) are <span style=\"color: #ff0000;\">down 12% </span>on Thursday, extending Wednesday's post-market losses, after the social media and AI tech giant recorded a one-time charge of nearly $16B after implementing President Donald Trump's OBBBA tax law, which impacted its bottom line in the third quarter.</p>\n<p>For the remainder of 2025 and years to come, the company expects significantly lower taxes from Trump's new tax law.  </p>\n<p>The company also warned that its expenses \"will grow at a \"significantly faster percentage rate,\" in 2026 as it would \"spend aggressively\" to achieve its goals to have crucial AI technology and infrastructure at its disposal.</p>\n<h2>Word on the Street</h2>\n<p><strong>Oppenheimer </strong>downgraded Meta's investment rating to \"perform\" from \"outperform\" and removed its price target following Q3 results and said risk/reward is \"properly reflected\" after the stock's plunge. The research firm said the company's significant investment in its AI superintelligence unit, despite the unknown revenue opportunity, mirrors 2021/2022 Metaverse spending.</p>\n<p><strong>Bernstein </strong>praised Meta's revenue growth driven by AI execution but said it was reminded of the \"Metaverse days\" after the company warned of climbing investment levels. Ad impressions were the primary revenue growth driver in Q3, though pricing growth was also strong; paid messaging revenue growth remains strong but small, the research firm said. The rating was maintained at \"buy,\" but the PT was cut by $30 to $870, a 15.7% upside.</p>\n<p><strong>Citigroup </strong>maintained its rating at \"buy\" but lowered its price target to $850 (13.1% upside), from $915. The research firm now expects lower profitability for 2026 due to the company's aggressive spending and investments next year. They also acknowledged that the magnitude of investments is greater than what most expected.</p>\n<p><strong>Truist Securities </strong>said it remained constructive on Meta and believes the company continues to earn the right to invest as long as it delivers faster top-line growth and FCFs in the near term. They also noted that Q3 results reflected robust ad share gains fueled by AI improvements across ad recommendations, monetization, and user growth/engagement. The rating was unchanged at \"buy,\" but the PT was lowered by $15 to $875, a 16.4% upside.</p>\n<p><strong>Piper Sandler </strong>called the results \"very impressive\" and said the pressure on shares from the expense commentary for 2026 is a buying opportunity. The research firm projected flat operating income for next year and said FCF will likely be down. They remain bullish on ad model investments like GEM, Lattice, and Andromeda. The rating was maintained at \"overweight,\" but PT was cut by $40 to $840, an 11.8% upside.</p>\n<p><strong>Bank of America</strong> said they expect Meta's stock to be controversial given a limited EPS growth outlook and y/y FCF pressure in 2026. However, they see the company in a position of strength with its massive user network and the opportunity to integrate compelling AI products, including content creation tools, over the next two years. </p>\n<p>\"We believe the bad news on expenses is now mostly in the stock, while product catalysts, including a new LLM and content creation tools, can drive upside engagement and revenue in 2026,\" the research firm said. The rating was maintained at \"buy,\" but the PT was cut by $90 to $810, a 7.8% upside. </p>\n<p><strong>Seeking Alpha analyst Ahan Vashi </strong>upgraded Meta to \"buy\" and said <a href=\"https://seekingalpha.com/article/4835045-meta-buy-the-q3-earnings-dip-rating-upgrade#scroll_comments\" rel=\"noopener noreferrer\" target=\"_blank\">the company's Q3 revenue and core KPIs were strong</a>, but a one-time ~$16B tax charge caused a sharp EPS drop and triggered a stock decline. </p>\n<p>Despite rising expenses and CAPEX, META's valuation is now attractive, with a 5-year CAGR return estimate of ~16%. Technical and fundamental analysis support a bullish outlook for META, with a target range of $850-1075 per share, Vashi said.</p>\n<p><strong>Seeking Alpha analyst Kenio Fontes </strong>also upgraded the company to a \"buy\" rating after the Q3 report and <a href=\"https://seekingalpha.com/article/4835059-meta-q3-selloff-looks-like-a-gift-for-long-term-investors-upgrade\" rel=\"noopener noreferrer\" target=\"_blank\">blamed the market overreaction</a> for the stock price decline stemming from the non-recurring tax charge. Fontes noted that Meta's core business remains strong, with 26% YoY revenue growth, robust ad impressions, and expanding AI and Reality Labs initiatives. </p>\n<p>He also highlighted that the stock now trades at a 2026 P/E of 23x, making the company the cheapest among the \"Magnificent Seven,\" enhancing its margin of safety. While ad dependence remains a concern, META's solid fundamentals and discounted valuation present a compelling medium- and long-term opportunity, Fontes said.</p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511469-analysts-largely-impressed-with-metas-q3-but-ai-spending-plans-remind-of-metaverse-days",
            "pub_date": "2025-10-31 00:05:38",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511512",
            "title": "Cleveland-Cliffs names Korea's Posco as new strategic partner",
            "description": "<html><body><p>Cleveland-Cliffs (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs Inc.\">CLF</a></span>) named South Korean steelmaker Posco Holdings (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/PKX\" title=\"POSCO Holdings Inc.\">PKX</a></span>) as its <a href=\"https://seekingalpha.com/pr/20286127-cleveland-cliffs-announces-posco-as-mou-counterparty-as-korea-trade-agreement-takes-effect\" target=\"_self\" title=\"new strategic partner\">new strategic partner</a> Thursday, identifying the company behind the previously disclosed \"transformative\" memorandum of understanding.</p>\n<p>\"The partnership will allow Posco to support and grow its established U.S. customer base while ensuring that its products meet U.S. trade and origin requirements,\" Cleveland-Cliffs (<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs Inc.\">CLF</a>) said, adding that it expects the ultimate outcome of the MoU to be \"highly accretive to shareholders\" but offering no details about the arrangement.</p>\n<p>Cliffs (<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs Inc.\">CLF</a>) said it expects a formal announcement on a definitive agreement in Q4 2025 or Q1 2026, with closing expected in 2026.</p>\n<p>The company's move represents a <a href=\"https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-10-30-2025/card/cleveland-cliffs-investors-bail-after-1-billion-share-offer-sFxzDq0WAUExWJO5GKwE\" rel=\"nofollow\" target=\"_self\" title=\"significant shift in strategy\">significant shift in strategy</a> for CEO Lourenco Goncalves, who waged a long, hostile campaign against the sale of rival US Steel to Japan's Nippon Steel and tried to acquire US Steel, argued that allowing a foreign company to buy the iconic U.S. company would hurt the American steel industry.</p>\n<p>Cliffs (<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs Inc.\">CLF</a>) shares <span style=\"color: #ff0000;\">-11.6%</span> in Thursday's trading on plans to <a href=\"https://seekingalpha.com/news/4510742-cleveland-cliffs-announces-proposed-offering-of-75m-common-shares\" target=\"_self\" title=\"issue 75 million shares\">issue 75 million shares</a> to pay down debt with an underwriters option to purchase 11.25 million additional shares; analysts expect the proceeds from the share sale to reduce the company's debt to ~$7 billion.</p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511512-cleveland-cliffs-names-koreas-posco-as-new-strategic-partner",
            "pub_date": "2025-10-31 00:01:12",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511481",
            "title": "Bristol rises on 2025 guidance raises, Q3 beats driven by Eliquis growth",
            "description": "<html><body><p>Bristol Myers Squibb (<span class=\"ticker-hover-wrapper\"><span class=\"ticker-hover-wrapper\"><span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/BMY\" title=\"Bristol-Myers Squibb Company\">BMY</a></span></span></span>) is <span style=\"color: #008000;\">up ~5%</span> in Thursday trading after boosting its 2025 revenue and EPS guidance following the release of its Q3 financial results that <a href=\"https://seekingalpha.com/news/4511179-bristol-myers-squibb-company-and-nbsp-non-gaap-eps-of-1_63-beats-by-0_11-revenue-of-12_22b\" target=\"_self\" title=\"beat\">beat</a> on both lines. </p>\n<p>The pharma now sees adjusted EPS for the year of $6.40-$6.60, from $6.35-$6.65 prior. Consensus is $6.36. Revenue is projected at $47.5B-$48, from $46.5B-$47.5B before. Consensus is $47.32B. </p>\n<p>Part of the reason for the increases is strong year-over-year sales performance for its two of its best-selling drugs, Eliquis (apixaban) and Opdivo (nivolumab). Eliquis, which is co-marketed with Pfizer (<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a>), saw a nearly 25% year-over-year increase to ~$3.7B. Opdivo revenue grew ~7% to $2.5B.</p>\n<p>The medicine with the highest percentage growth compared to Q3 2024 -- 89% -- was Camzyos (mavacamten), bringing in $296M.</p>\n<p>Two of its legacy medicines, Revlimid (lenalidomide) and Pomalyst/Imnovid (pomalidomide), saw sharp year-over-year revenue decreases of, respectively, 59% and 25%, to $575M and $675M. While both drugs are used to treat multiple myeloma, Revlimid is available as a generic. Pomalyst is expected to go generic in 2026 Q1.</p>\n<p>In Q3, non-GAAP EPS of $1.63 compared to $1.80 in the year-ago period. Bristol was negatively impacted in the quarter by higher cost of products sold, R&amp;D, and acquired IPR&amp;D expenses compared to Q3 2024.</p>\n<p>The company ended the quarter (Sept. 30) with cash, cash equivalents, and marketable debt securities of $16.9B compared to $11.2B on Dec. 31, 2024. </p>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511481-bristol-rises-2025-guidance-raises-q3-beats-driven-eliquis-growth",
            "pub_date": "2025-10-31 00:01:12",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511493",
            "title": "EU financial stocks rise fivefold versus U.S. counterparts YTD",
            "description": "<html><body><p>European financial stocks have sharply outpaced their U.S. counterparts so far this year, reversing a multi-year trend of U.S. market outperformance.</p>\n<p>The iShares MSCI Europe Financials ETF (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/EUFN\" title=\"iShares MSCI Europe Financials ETF\">EUFN</a></span>) <span style=\"color: #008000;\">surged 46%</span> year-to-date as of Thursday midday trading, compared with the U.S. Financial Select Sector SPDR Fund ETF's (<span class=\"ticker-hover-wrapper\"><a href=\"https://seekingalpha.com/symbol/XLF\" title=\"The Financial Select Sector SPDR® Fund ETF\">XLF</a></span>) mere <span style=\"color: #008000;\">8.8% climb</span>. The divergence unfolds amid a broader shift in which EU equities (<a href=\"https://seekingalpha.com/symbol/FEZ\" title=\"SPDR® EURO STOXX 50 ETF\">FEZ</a>) have notably <a href=\"https://seekingalpha.com/symbol/XLF/charting?compare=XLF%2CEUFN%2CSPY%2CFEZ&amp;interval=YTD\" target=\"_blank\" title=\"outpaced\">outpaced</a> the U.S. stock market (<a href=\"https://seekingalpha.com/symbol/SPY\" title=\"SPDR® S&amp;P 500® ETF\">SPY</a>).</p>\n<p>That helped extend relative outperformance far beyond this year, with EUFN <span style=\"color: #008000;\">+157%</span> in the <a href=\"https://seekingalpha.com/symbol/XLF/charting?compare=XLF%2CEUFN%2CSPY%2CFEZ&amp;interval=5Y\" target=\"_blank\" title=\"past five years\">past five years</a> vs. XLF <span style=\"color: #008000;\">+121%</span> over the same period. Zooming even further out, though, the U.S. was still a <a href=\"https://seekingalpha.com/symbol/XLF/charting?compare=XLF%2CEUFN%2CSPY%2CFEZ&amp;interval=MAX\" target=\"_blank\" title=\"clear winner.\">clear winner.</a></p>\n<p>Among some of EUFNs largest holdings include HSBC Holdings (<a href=\"https://seekingalpha.com/symbol/HSBC\" title=\"HSBC Holdings plc\">HSBC</a>), Allianz (<a href=\"https://seekingalpha.com/symbol/ALIZF\" title=\"Allianz SE\">OTCPK:ALIZF</a>) (<a href=\"https://seekingalpha.com/symbol/ALIZY\" title=\"Allianz SE\">OTCPK:ALIZY</a>), Banco Santander (<a href=\"https://seekingalpha.com/symbol/SAN\" title=\"Banco Santander, S.A.\">SAN</a>), UBS Group (<a href=\"https://seekingalpha.com/symbol/UBS\" title=\"UBS Group AG\">UBS</a>), Banco Bilbao Vizcaya Argentaria (<a href=\"https://seekingalpha.com/symbol/BBVA\" title=\"Banco Bilbao Vizcaya Argentaria, S.A.\">BBVA</a>) and UniCredit (<a href=\"https://seekingalpha.com/symbol/UNCFF\" title=\"UniCredit S.p.A.\">OTCPK:UNCFF</a>) (<a href=\"https://seekingalpha.com/symbol/UNCRY\" title=\"UniCredit S.p.A.\">OTCPK:UNCRY</a>).</p>\n<p>Top-weight holdings in XLF feature Berkshire Hathaway (<a href=\"https://seekingalpha.com/symbol/BRK.A\" title=\"Berkshire Hathaway Inc.\">BRK.A</a>) (<a href=\"https://seekingalpha.com/symbol/BRK.B\" title=\"Berkshire Hathaway Inc.\">BRK.B</a>), JPMorgan Chase (<a href=\"https://seekingalpha.com/symbol/JPM\" title=\"JPMorgan Chase &amp; Co.\">JPM</a>), Visa (<a href=\"https://seekingalpha.com/symbol/V\" title=\"Visa Inc.\">V</a>), Mastercard (<a href=\"https://seekingalpha.com/symbol/MA\" title=\"Mastercard Incorporated\">MA</a>), Bank of America (<a href=\"https://seekingalpha.com/symbol/BAC\" title=\"Bank of America Corporation\">BAC</a>), Wells Fargo (<a href=\"https://seekingalpha.com/symbol/WFC\" title=\"Wells Fargo &amp; Company\">WFC</a>), Goldman Sachs (<a href=\"https://seekingalpha.com/symbol/GS\" title=\"The Goldman Sachs Group, Inc.\">GS</a>), Morgan Stanley (<a href=\"https://seekingalpha.com/symbol/MS\" title=\"Morgan Stanley\">MS</a>) and Citigroup (<a href=\"https://seekingalpha.com/symbol/C\" title=\"Citigroup Inc.\">C</a>).</p>\n<figure class=\"regular-img-figure\" contenteditable=\"false\"><img alt=\"Year-to-date price returns for XLF, EUFN, SPY and FEZ\" data-caption=\"Year-to-date price returns for XLF, EUFN, SPY and FEZ\" data-original-src=\"https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/35e73028dee54b721653bd649278e05b.png\" data-rel=\"lightbox\" data-source=\"Seeking Alpha\" fetchpriority=\"high\" height=\"360\" sizes=\"(max-width: 768px) calc(100vw - 36px), (max-width: 1024px) calc(100vw - 180px), 552px\" src=\"https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/35e73028dee54b721653bd649278e05b.png?io=w640\" srcset=\"https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/35e73028dee54b721653bd649278e05b.png?io=w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/35e73028dee54b721653bd649278e05b.png?io=w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/35e73028dee54b721653bd649278e05b.png?io=w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/35e73028dee54b721653bd649278e05b.png?io=w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/35e73028dee54b721653bd649278e05b.png?io=w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/35e73028dee54b721653bd649278e05b.png?io=w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/35e73028dee54b721653bd649278e05b.png?io=w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/35e73028dee54b721653bd649278e05b.png?io=w240 240w\" width=\"900\"/><figcaption class=\"overlay-title\"><p class=\"item-caption\">Year-to-date price returns for XLF, EUFN, SPY and FEZ<span class=\"item-source\"> (Seeking Alpha) </span></p></figcaption></figure><p> </p>\n</body></html>",
            "image": "https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/35e73028dee54b721653bd649278e05b.png?io=w640",
            "link": "https://seekingalpha.com/news/4511493-eu-financial-stocks-rise-fivefold-versus-us-counterparts-ytd",
            "pub_date": "2025-10-30 23:55:49",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511518",
            "title": "Agricultural Bank of China reports Q3 results",
            "description": "<html><body><ul>\n<li>Agricultural Bank of China <a href=\"https://www.abchina.com/en/investor-relations/corporate-announcements/Announcements/202510/t20251030_2503532.htm\" rel=\"nofollow\" target=\"_blank\">press release</a>  (ACGBY): Q3 diluted earnings per share of RMB 0.22.</li>\n<li>Operating income of RMB 180.98B (+4.3% Y/Y).</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511518-agricultural-bank-of-china-reports-q3-results",
            "pub_date": "2025-10-30 23:50:49",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511519",
            "title": "PUMA SE GAAP EPS of -€0.42, revenue of €1.96B",
            "description": "<html><body><ul>\n<li>PUMA SE <a href=\"https://about.puma.com/sites/default/files/financial-report/2025/puma-q3-2025-release-english-final.pdf\" rel=\"nofollow\" target=\"_blank\">press release</a>  (PMMAF): Q3  GAAP EPS of -€0.42.</li>\n<li>Revenue of €1.96B (-15.2% Y/Y).</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511519-puma-se-gaap-eps-of-042-revenue-of-196b",
            "pub_date": "2025-10-30 23:50:49",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4511513",
            "title": "Höegh Autoliners ASA reports Q3 results",
            "description": "<html><body><ul>\n<li>Höegh Autoliners ASA <a href=\"https://investors.hoeghautoliners.com/investors/ir-news/news-details/2025/Hegh-Autoliners-ASA-Third-quarter-results-and-distribution-of-dividends/default.aspx\" rel=\"nofollow\" target=\"_blank\">press release</a>  (HOEGF): Q3 net profit after tax of $131 million.</li>\n<li>Gross revenue of USD 370 million/NOK 3,941 million.</li>\n<li>Operating profit (EBITDA) was USD 155 million/NOK 1,650 million.</li>\n<li>\n<strong>Outlook:</strong> Tariffs may over time result in lower volumes transported. Significant changes to new U.S. port fees were announced 10 October, with implementation from 14 October. The yearly impact is estimated to be ~USD 60-70 million, the company is working diligently to mitigate the impact.</li>\n<li>Q4 operational performance is projected to be slightly below the Q3 EBITDA. In addition, USTR impact is expected to be ~USD 20 million for the quarter.</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
            "link": "https://seekingalpha.com/news/4511513-hoegh-autoliners-asa-reports-q3-results",
            "pub_date": "2025-10-30 23:45:44",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        }
    ]
}